Peter Andreasen
Overview
Explore the profile of Peter Andreasen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pincha N, Hajam E, Badarinath K, Batta S, Masudi T, Dey R, et al.
J Clin Invest
. 2018 Mar;
128(5):1807-1819.
PMID: 29584619
Fibrosis is a prevalent pathological condition arising from the chronic activation of fibroblasts. This activation results from the extensive intercellular crosstalk mediated by both soluble factors and direct cell-cell connections....
2.
Gong L, Proulle V, Fang C, Hong Z, Lin Z, Liu M, et al.
J Cell Mol Med
. 2016 May;
20(10):1851-60.
PMID: 27197780
Fibrinolysis is a process responsible for the dissolution of formed thrombi to re-establish blood flow after thrombus formation. Plasminogen activator inhibitor-1 (PAI-1) inhibits urokinase-type and tissue-type plasminogen activator (uPA and...
3.
4.
Kietzmann T, Andreasen P
Thromb Haemost
. 2009 Jan;
100(6):965-8.
PMID: 19132218
No abstract available.
5.
Offersen B, Pfeiffer P, Andreasen P, Overgaard J
Lung Cancer
. 2007 Jan;
56(1):43-50.
PMID: 17207889
Background: Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) have previously been suggested as prognostic markers in nonsmall-cell lung carcinomas (NSCLC). We investigate whether uPA and PAI-1 are...
6.
Jensen C, Lindsay K, Andreasen P, Skrydstrup T
J Org Chem
. 2005 Sep;
70(19):7512-9.
PMID: 16149778
[reaction: see text] A hydroxyethylene isostere of the tripeptide Arg-Gly-Leu, representing an important fragment of a novel cyclic-peptide-based uPA inhibitor, was synthesized in few steps employing as the key step...
7.
Usher P, Thomsen O, Iversen P, Johnsen M, Brunner N, Hoyer-Hansen G, et al.
Int J Cancer
. 2004 Oct;
113(6):870-80.
PMID: 15515049
The plasminogen activation (PA) cascade participates in degradation of extracellular matrix during cancer invasion. We have studied the expression of urokinase-type plasminogen activator (uPA) mRNA, uPA receptor (uPAR) mRNA and...